(Q44249011)

1 December 2017

title

Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesis (English)

1 reference

1 December 2017

1 reference

Stylianos Kontos

1

1 reference

1 December 2017

Athina Kominea

2

1 reference

1 December 2017

Maria Melachrinou

3

1 reference

1 December 2017

Eleni Balampani

4

1 reference

1 December 2017

Georgia Sotiropoulou-Bonikou

5

1 reference

1 December 2017

publication date

1 September 2010

1 reference

International Journal of Urology

1 December 2017

published in

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

9

1 reference

1 December 2017

page(s)

801-809

1 reference

Clinical model of lifetime cost of treating bladder cancer and associated complications

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Understanding urothelial carcinoma through cancer pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Minireview: estrogen and mouse models of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Nuclear factor-kappaB: its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Transcription factor cross-talk: the estrogen receptor and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Nuclear factor-kappa B is upregulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

The Molecular Pharmacology of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Anatomy of the estrogen response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Cloning and characterization of human estrogen receptor beta isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Coordinated upregulation of COX-2 and NF-kappaB is a steady feature of laryngeal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Nuclear factor kappa B--molecular biomedicine: the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factor-kappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Estrogen actions in the ovary revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

NF-κB nuclear localization and its prognostic significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2010.02603.X

10.1111/J.1442-2042.2010.02603.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference